Mafuvadze B - Search Results

1

Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.

Mafuvadze B, Benakanakere I, López Pérez FR, Besch-Williford C, Ellersieck MR, Hyder SM. Mafuvadze B, et al. Cancer Prev Res (Phila). 2011 Aug;4(8):1316-24. doi: 10.1158/1940-6207.CAPR-10-0382. Epub 2011 Apr 19. Cancer Prev Res (Phila). 2011. PMID: 21505181 Free PMC article.

2

Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells.

Mafuvadze B, Benakanakere I, Hyder SM. Mafuvadze B, et al. Menopause. 2010 Sep-Oct;17(5):1055-63. doi: 10.1097/gme.0b013e3181dd052f. Menopause. 2010. PMID: 20551847

3

Differential expression of FGF family members in a progestin-dependent BT-474 human breast cancer xenograft model.

López Pérez FR, Liang Y, Besch-Williford CL, Mafuvadze B, Hyder SM. López Pérez FR, et al. Among authors: mafuvadze b. Histol Histopathol. 2012 Mar;27(3):337-45. doi: 10.14670/HH-27.337. Histol Histopathol. 2012. PMID: 22237711

4

Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors.

Mafuvadze B, Liang Y, Besch-Williford C, Zhang X, Hyder SM. Mafuvadze B, et al. Horm Cancer. 2012 Aug;3(4):160-71. doi: 10.1007/s12672-012-0114-x. Epub 2012 May 9. Horm Cancer. 2012. PMID: 22569706 Free PMC article.

5

Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model.

Mafuvadze B, Cook M, Xu Z, Besch-Williford CL, Hyder SM. Mafuvadze B, et al. Nutr Cancer. 2013;65(8):1184-91. doi: 10.1080/01635581.2013.833637. Epub 2013 Oct 15. Nutr Cancer. 2013. PMID: 24127693

6

Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.

Cook MT, Mafuvadze B, Besch-Williford C, Ellersieck MR, Goyette S, Hyder SM. Cook MT, et al. Among authors: mafuvadze b. Oncol Rep. 2016 Feb;35(2):825-32. doi: 10.3892/or.2015.4431. Epub 2015 Nov 17. Oncol Rep. 2016. PMID: 26719029

7

Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071.

Liang Y, Besch-Williford C, Aebi JD, Mafuvadze B, Cook MT, Zou X, Hyder SM. Liang Y, et al. Among authors: mafuvadze b. Breast Cancer Res Treat. 2014 Jul;146(1):51-62. doi: 10.1007/s10549-014-2996-5. Epub 2014 May 31. Breast Cancer Res Treat. 2014. PMID: 24878988 Free PMC article.

8

Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.

Mafuvadze B, Liang Y, Hyder SM. Mafuvadze B, et al. Oncol Rep. 2014 Oct;32(4):1727-33. doi: 10.3892/or.2014.3332. Epub 2014 Jul 15. Oncol Rep. 2014. PMID: 25051231

9

Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.

Cook MT, Liang Y, Besch-Williford C, Goyette S, Mafuvadze B, Hyder SM. Cook MT, et al. Among authors: mafuvadze b. Springerplus. 2015 Aug 22;4:444. doi: 10.1186/s40064-015-1242-x. eCollection 2015. Springerplus. 2015. PMID: 26312209 Free PMC article.

10

Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells.

Liang Y, Mafuvadze B, Aebi JD, Hyder SM. Liang Y, et al. Among authors: mafuvadze b. Onco Targets Ther. 2016 May 30;9:3223-32. doi: 10.2147/OTT.S105725. eCollection 2016. Onco Targets Ther. 2016. PMID: 27313468 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters